A Theranostic Approach to Target Gastrin in Pancreatic Cancer

A Theranostic Approach to Target Gastrin in Pancreatic Cancer

Bibliographic Details
Main Authors:	Sulagna Banerjee, PhD, Ashok K. Saluja, PhD
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X18300559

Similar Items

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
by: Vineet K. Gupta, et al.
Published: (2020-01-01)

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
by: Ayman Abouzayed, et al.
Published: (2023-07-01)

Biocompatible Polymer Nano-Constructs: A Potent Platform for Cancer Theranostics
by: Himani Kalita PhD, et al.
Published: (2023-03-01)

Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging
by: Donald A. Fernandes PhD
Published: (2023-08-01)

A rare case of Ewing sarcoma with elevated plasma pro-gastrin-releasing peptide (proGRP) level
by: Yoshitane Tsukamoto, MD, PhD, et al.
Published: (2016-12-01)

Gastrin and Gastric CancerSummary
by: Jill P. Smith, et al.
Published: (2017-07-01)

GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
by: Patricia Dauer, et al.
Published: (2018-09-01)

The application of FAPI-targeted theranostics in pancreatic cancer: a narrative review
by: Meixi Liu, et al.
Published: (2022-06-01)

Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles
by: Heike E. Daldrup-Link MD, PhD
Published: (2017-09-01)

The central role of gastrin in gastric cancer
by: Helge Waldum, et al.
Published: (2023-10-01)

Pancreatitis and Pancreatic Cancer Risk
by: Dong-Mei Ma MD, et al.
Published: (2023-03-01)

From Micro- to Nano-Multifunctional Theranostic Platform: Effective Ultrasound Imaging Is Not Just a Matter of Scale
by: Sara Zullino MSc, et al.
Published: (2018-09-01)

Gastrin and the Moderate Hypergastrinemias
by: Jens F. Rehfeld
Published: (2021-06-01)

Ovarian Cancer Targeted Theranostics
by: Sridhar Nimmagadda, et al.
Published: (2020-01-01)

Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
by: Beata Paulina Rurarz, et al.
Published: (2023-02-01)

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
by: Q. Li, et al.
Published: (2020-08-01)

Fibroblast activation protein-based theranostics in pancreatic cancer
by: Chien-shan Cheng, et al.
Published: (2022-10-01)

Adjuvant and neoadjuvant therapy for pancreatic cancer
by: Shimpei Maeda, MD, PhD, et al.
Published: (2019-09-01)

A Beam-Specific Optimization Target Volume for Stereotactic Proton Pencil Beam Scanning Therapy for Locally Advanced Pancreatic Cancer
by: Dong Han, PhD, et al.
Published: (2021-11-01)

Pancreatic beta cells express the fetal islet hormone gastrin in rodent and human diabetes
by: Dahan, T, et al.
Published: (2016)

Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
by: Honghu Zhang, et al.
Published: (2024-12-01)

Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
by: Chao Qu PhD, et al.
Published: (2018-12-01)

Cyclodextrin nanoparticles in targeted cancer theranostics
by: Roshnee Bose, et al.
Published: (2023-08-01)

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer
by: Olivia McGinn, et al.
Published: (2017-08-01)

Carbohydrate 3′-sialyllactose as a novel target for theranostics in pancreatic ductal adenocarcinoma
by: Kiyoshi Higashi, et al.
Published: (2020-10-01)

The Achilles’ Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials
by: Despina Siolas, MD, PhD, et al.
Published: (2020-09-01)

Tracing the Origin of Fibroblasts in Pancreatic Cancer
by: Giulia Biffi, PhD
Published: (2020-01-01)

Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
by: Samuli I. Nissinen MD, et al.
Published: (2021-10-01)

Recharacterization data for a geriatric gastrin polycolonal antibody
by: Steven Dodd, et al.
Published: (2019-06-01)

Successful Laparoscopic Treatment of Pancreatic Metastasis From Sigmoid Colon Cancer: A Case Report
by: Masatsugu Ishii MD, PhD, et al.
Published: (2022-04-01)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
by: Suphalak Khamruang Marshall, et al.
Published: (2022-10-01)

Analytical aspects of gastrin measurement in neuroendocrine tumors
by: N. V. Lyubimova, et al.
Published: (2018-08-01)

A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
by: Nicolas Aide, et al.
Published: (2021-02-01)

Aptamer Nanomaterials for Ovarian Cancer Target Theranostics
by: Jing Zhao, et al.
Published: (2022-03-01)

Mitochondria-targeting theranostics
by: Han Chang Kang
Published: (2018-11-01)

Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy
by: Husain Yar Khan, PhD, et al.
Published: (2023-01-01)

Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care
by: Yair Maimon PhD, et al.
Published: (2018-12-01)

PSMA Theranostics: Current Status and Future Directions
by: Kambiz Rahbar MD, et al.
Published: (2018-06-01)

A case of improved quality of life in a patient with inoperable pancreatic cancer after repeated RFA
by: Nino Toria, MD, et al.
Published: (2022-10-01)

Subcellular targeting of theranostic radionuclides
by: Bavelaar, B, et al.
Published: (2018)